23 Feb I Peace
Koji Tanabe, Ph.D., CEO and Founder
Palo Alto, CA
Founded in 2015, I Peace’s mission is to alleviate patient suffering and help healthy people maintain high quality of life. I Peace’s proprietary manufacturing platform enables the fully-automated mass production of discrete iPSCs from multiple donors in a single room. Increasing the available number of clinical-grade iPSC lines allows our customers to take differentiation propensity into account to select the most appropriate iPSC line for their clinical research at significantly reduced cost. Our goal is to create clinical-grade iPSCs for every individual. We offer off-the-shelf clinical-grade iPSC lines and custom manufacturing capabilities. We have a GMP facility authorized by the PMDA and cGMP certified that is capable of full automation to generate iPSCs on a mass scale to dramatically reduce cost. Our team is led by Koji Tanabe who is the second author of the world’s first human iPSC paper.